BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 21518820)

  • 1. SOX2 expression and amplification in gliomas and glioma cell lines.
    Annovazzi L; Mellai M; Caldera V; Valente G; Schiffer D
    Cancer Genomics Proteomics; 2011; 8(3):139-47. PubMed ID: 21518820
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sox2 expression in brain tumors: a reflection of the neuroglial differentiation pathway.
    Phi JH; Park SH; Kim SK; Paek SH; Kim JH; Lee YJ; Cho BK; Park CK; Lee DH; Wang KC
    Am J Surg Pathol; 2008 Jan; 32(1):103-12. PubMed ID: 18162777
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Forced expression of Sox21 inhibits Sox2 and induces apoptosis in human glioma cells.
    Ferletta M; Caglayan D; Mokvist L; Jiang Y; Kastemar M; Uhrbom L; Westermark B
    Int J Cancer; 2011 Jul; 129(1):45-60. PubMed ID: 20824710
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression profile of embryonic stem cell-associated genes Oct4, Sox2 and Nanog in human gliomas.
    Guo Y; Liu S; Wang P; Zhao S; Wang F; Bing L; Zhang Y; Ling EA; Gao J; Hao A
    Histopathology; 2011 Oct; 59(4):763-75. PubMed ID: 22014056
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Aberrant expression of sox2 gene in malignant gliomas].
    Volnitskiĭ AV; Semenova EV; Shtam TA; Kovalev RA; Filatov MV
    Tsitologiia; 2014; 56(7):504-10. PubMed ID: 25696994
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Arsenic trioxide regulates the apoptosis of glioma cell and glioma stem cell via down-regulation of stem cell marker Sox2.
    Sun H; Zhang S
    Biochem Biophys Res Commun; 2011 Jul; 410(3):692-7. PubMed ID: 21703238
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of tissue factor correlates with grade of malignancy in human glioma.
    Hamada K; Kuratsu J; Saitoh Y; Takeshima H; Nishi T; Ushio Y
    Cancer; 1996 May; 77(9):1877-83. PubMed ID: 8646688
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of transforming growth factor alpha in human gliomas.
    Schlegel U; Moots PL; Rosenblum MK; Thaler HT; Furneaux HM
    Oncogene; 1990 Dec; 5(12):1839-42. PubMed ID: 2284103
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [CDK1 expression and effects of CDK1 silencing on the malignant phenotype of glioma cells].
    Chen H; Huang Q; Zhai DZ; Dong J; Wang AD; Lan Q
    Zhonghua Zhong Liu Za Zhi; 2007 Jul; 29(7):484-8. PubMed ID: 18069625
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression analysis of the autosomal recessive primary microcephaly genes MCPH1 (microcephalin) and MCPH5 (ASPM, abnormal spindle-like, microcephaly associated) in human malignant gliomas.
    Hagemann C; Anacker J; Gerngras S; Kühnel S; Said HM; Patel R; Kämmerer U; Vordermark D; Roosen K; Vince GH
    Oncol Rep; 2008 Aug; 20(2):301-8. PubMed ID: 18636190
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Allelic losses at 1p36 and 19q13 in gliomas: correlation with histologic classification, definition of a 150-kb minimal deleted region on 1p36, and evaluation of CAMTA1 as a candidate tumor suppressor gene.
    Barbashina V; Salazar P; Holland EC; Rosenblum MK; Ladanyi M
    Clin Cancer Res; 2005 Feb; 11(3):1119-28. PubMed ID: 15709179
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Loss of the AP-2alpha transcription factor is associated with the grade of human gliomas.
    Heimberger AB; McGary EC; Suki D; Ruiz M; Wang H; Fuller GN; Bar-Eli M
    Clin Cancer Res; 2005 Jan; 11(1):267-72. PubMed ID: 15671555
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased expression of Akt2 and activity of PI3K and cell proliferation with the ascending of tumor grade of human gliomas.
    Wang G; Kang C; Pu P
    Clin Neurol Neurosurg; 2010 May; 112(4):324-7. PubMed ID: 20116920
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sox2 is translationally activated by eukaryotic initiation factor 4E in human glioma-initiating cells.
    Ge Y; Zhou F; Chen H; Cui C; Liu D; Li Q; Yang Z; Wu G; Sun S; Gu J; Wei Y; Jiang J
    Biochem Biophys Res Commun; 2010 Jul; 397(4):711-7. PubMed ID: 20537983
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Using gene expression profiling to identify a prognostic molecular spectrum in gliomas.
    Shirahata M; Oba S; Iwao-Koizumi K; Saito S; Ueno N; Oda M; Hashimoto N; Ishii S; Takahashi JA; Kato K
    Cancer Sci; 2009 Jan; 100(1):165-72. PubMed ID: 19038000
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Patients with IDH1 wild type anaplastic astrocytomas exhibit worse prognosis than IDH1-mutated glioblastomas, and IDH1 mutation status accounts for the unfavorable prognostic effect of higher age: implications for classification of gliomas.
    Hartmann C; Hentschel B; Wick W; Capper D; Felsberg J; Simon M; Westphal M; Schackert G; Meyermann R; Pietsch T; Reifenberger G; Weller M; Loeffler M; von Deimling A
    Acta Neuropathol; 2010 Dec; 120(6):707-18. PubMed ID: 21088844
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential expression of membrane-type matrix metalloproteinase and its correlation with gelatinase A activation in human malignant brain tumors in vivo and in vitro.
    Yamamoto M; Mohanam S; Sawaya R; Fuller GN; Seiki M; Sato H; Gokaslan ZL; Liotta LA; Nicolson GL; Rao JS
    Cancer Res; 1996 Jan; 56(2):384-92. PubMed ID: 8542596
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of a Sox2 reporter system modeling cellular heterogeneity in glioma.
    Stoltz K; Sinyuk M; Hale JS; Wu Q; Otvos B; Walker K; Vasanji A; Rich JN; Hjelmeland AB; Lathia JD
    Neuro Oncol; 2015 Mar; 17(3):361-71. PubMed ID: 25416826
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SOX2 identified as a target gene for the amplification at 3q26 that is frequently detected in esophageal squamous cell carcinoma.
    Gen Y; Yasui K; Zen Y; Zen K; Dohi O; Endo M; Tsuji K; Wakabayashi N; Itoh Y; Naito Y; Taniwaki M; Nakanuma Y; Okanoue T; Yoshikawa T
    Cancer Genet Cytogenet; 2010 Oct; 202(2):82-93. PubMed ID: 20875870
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Shared molecular targets in pediatric gliomas and ependymomas.
    Tsuruta T; Aihara Y; Kanno H; Funase M; Murayama T; Osawa M; Fujii H; Kubo O; Okada Y
    Pediatr Blood Cancer; 2011 Dec; 57(7):1117-23. PubMed ID: 21298772
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.